Boston, MA & Singapore – October 3, 2022 – AIM Biotech announced the launch of the organiX System, a lab tool to closely model human disease by adding vascularization and immune competence to organoids, spheroids and tumor biopsies. Adding vascularization and immune cells to a disease model creates a more defined and tunable microenvironment to more closely emulate the complexity of human physiology. This is all packag
Home News Item AIM Biotech Launches organiX, A New System to Model Human Disease by Combining Organoids, Perfusable Vasculature and Immune-Competence

AIM Biotech Launches organiX, A New System to Model Human Disease by Combining Organoids, Perfusable Vasculature and Immune-Competence
oktober 03, 2022by Reacties uitgeschakeld voor AIM Biotech Launches organiX, A New System to Model Human Disease by Combining Organoids, Perfusable Vasculature and Immune-Competence
Previous Post
Indian hockey teams to play 'Test' series against Australia in Adelaide
Next Post
Pak army soldier killed in Khyber Pakhtunkhwa attack